David J. Hanna, DO, MSc, CNSC

Proud of my brother @DHannaMD Innovative idea, excellent execution! Night Float, Simulated: A Missing Piece of Cardiology Fellowship tctmd.com/news/night-flo…

What we suspected but now confirmed ....Improvement in fibrosis with semaglutide! Does this change your management? Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis | New England Journal of Medicine nejm.org/doi/pdf/10.105…

Five ways your diet and lifestyle can reduce your risk of colorectal cancer... March is colorectal cancer awareness month.... Get your screening today! riversideonline.com/en/patients-an… #colon #coloncancerawareness #Cancer #CancerResearch #coloncancerawareness #colonoscopy #cancerscreen

I love eponyms! Here is one of my favorites: Courvoisier's gallbladder (or sign). Painless palpable GB, from biliary obstruction usually due to panc CA. Weight loss, as in this case, makes it easier to palpate. @DouglasAdlerMD #GITwitter @ASGEendoscopy @RuchitShahDO @drkeithsiau

Honored to be part of an institution with such wonderful interdisciplinary collaboration both clinically and in research! Thankful for the Obesity Institute @GeisingerHealth @GeisingerGi ncbi.nlm.nih.gov/pmc/articles/P… #obesity #NAFLD #bariatric @ObesitySociety @AASLDtweets @IamCPlus

Congratulations to our new GI PD, Dr. Bradley Confer and APD, Dr. Benyam Addissie! Dr. Confer completed his General GI & Advanced Endoscopy fellowships at the Cleveland Clinic, OH. Dr. Addissie completed his general GI & Transplant Hepatology fellowships at the Mayo Clinic, MN.

Bariatric endoscopy table from Obesity Primer for the Practicing Gastroenterologist in the red journal.

Editorial discusses the challenges and opportunities of confirmatory testing for eradication of H. pylori ow.ly/r62L50Dsh9L

Stay Tuned for the New Guideline to Evaluate NAFLD. If you patient is older then65 use a FIB-4 cutoff of 2.0

“Patients with NAFLD who underwent endoscopic bariatric and metabolic therapies saw improvements in liver fibrosis and other outcomes”... Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis cghjournal.org/article/S1542-…

Understanding adaptations in gastrointestinal physiology after #Bariatricsurgery is crucial to optimise postoperative drug therapy and prevent nutritional deficiencies. Our #review in @LancetGastroHep outlines current knowledge. Work of @NeleSteenackers doi.org/10.1016/S2468-…

The data we were waiting on, to improve insurance coverage for our patients without diabetes who need help with weight management. #obesity #semaglutide #weightloss @GeisingerGi @GeisingerHealth

Honored to be an ABOM diplomate trained under Dr. Christopher Still @GeisingerGi @GeisingerHealth #obesity @OMAsocial @BariatricTimes @ObesityMedicine @ObesitySociety @WorldObesity @ASMBS pub-press.mydigitalpublication.com/publication/?m…

Always helpful #GItwitter to clinically apply to recent cases @GeisingerGi

Bariatric Surgery & SIBO

Welcome to the official Twitter page for the @GeisingerHealth Department of Gastroenterology & Hepatology. We look forward to sharing information about our fellowship program, academic endeavors, and clinical experiences. #FutureofGI #GITwitter #MedEd

Starting #GIFellowship on July 1st? The founders of #LFN put together their “top 10” tips to help new trainees navigate fellowship training! liverfellow.org/post/top-10-ti… What other tips do you have for incoming GI fellows? Reply below 👇 #livertwitter #MedEd #FOAMed #GIFellows

New AGA clinical guidelines: we do not recommend the use of #probiotics for most digestive conditions. Correct the unbiased info out there & please retweet. ow.ly/bpw450A2MFA

Signs and symptoms of #celiacdisease are variable and may be subtle. People with celiac disease can have very different symptoms from each other. Careful evaluation is important to make the diagnosis. #CeliacDiseaseAwareness #PAGastro